Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › β-L-2′-deoxy-nucleosides for the treatment of hepatitis B

β-L-2′-deoxy-nucleosides for the treatment of hepatitis B

US Patent 9290533 · Granted Mar 22, 2016

Estimated economic value: $9,484,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2′-chloro nucleoside analogs for HCV infection2019
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for2019
Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosid2019
3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HC2019
1′,4′-thio nucleosides for the treatment of HCV2018
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compos2016
3′-deoxy nucleosides for the treatment of HCV2016
3′,5′-cyclic phosphate prodrugs for HCV infection2016
Compounds and pharmaceutical compositions for the treatment of viral infections2016
Compounds and pharmaceutical compositions for the treatment of viral infections2016
4′-fluoro nucleosides for the treatment of HCV2015
Purine nucleoside analogues for treating flaviviridae including hepatitis C2015